BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7150332)

  • 1. Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrances in glucuronidation kinetics by inhibition of sulfation.
    Koster H; Halsema I; Scholtens E; Pang KS; Mulder GJ
    Biochem Pharmacol; 1982 Oct; 31(19):3023-8. PubMed ID: 7150332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
    Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
    J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
    Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
    J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.
    Krijgsheld KR; Koster HJ; Scholtens E; Mulder GJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):731-4. PubMed ID: 7086685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation.
    Mulder GJ; Weitering JG; Scholtens E; Dawson JR; Pang KS
    Biochem Pharmacol; 1984 Oct; 33(19):3081-7. PubMed ID: 6487358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing sulfation in isolated rat hepatocytes.
    Sundheimer DW; Brendel K
    Life Sci; 1984 Jan; 34(1):23-9. PubMed ID: 6694509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sulfation of phenols in vivo by 2,6-dichloro-4-nitrophenol: selectivity of its action in relation to other conjugations in the rat in vivo.
    Koster H; Scholtens E; Mulder GJ
    Med Biol; 1979 Oct; 57(5):340-4. PubMed ID: 522521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes.
    Sundheimer DW; Brendel K
    Drug Metab Dispos; 1983; 11(5):433-40. PubMed ID: 6138228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of sulfation in the rat in vivo and in the perfused rat liver.
    Mulder GJ
    Fed Proc; 1986 Jul; 45(8):2229-34. PubMed ID: 3087784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous distribution of the conjugation activity of acetaminophen and p-nitrophenol in isolated rat liver cells.
    Araya H; Mizuma T; Horie T; Hayashi M; Awazu S
    J Pharmacobiodyn; 1986 Feb; 9(2):218-22. PubMed ID: 3712218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations.
    Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ
    J Pharmacol Exp Ther; 1981 Oct; 219(1):134-40. PubMed ID: 7288601
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibition of sulfate conjugation in the rat: pharmacokinetics and characterization of the inhibitory effect of 2,6-dichloro-4-nitrophenol.
    Koster H; Halsema I; Scholtens E; Meerman JH; Pang KS; Mulder GJ
    Biochem Pharmacol; 1982 May; 31(10):1919-24. PubMed ID: 7104024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous distribution of conjugation activities of harmol in isolated rat liver cells.
    Araya H; Mizuma T; Horie T; Hayashi M; Awazu S
    J Pharmacobiodyn; 1984 Sep; 7(9):624-9. PubMed ID: 6098639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation.
    Fayz S; Cherry WF; Dawson JR; Mulder GJ; Pang KS
    Drug Metab Dispos; 1984; 12(3):323-9. PubMed ID: 6145559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
    Noort D; Meijer EA; Visser TJ; Meerman JH; Van der Marel GA; Van Boom JH; Mulder GJ
    Mol Pharmacol; 1991 Aug; 40(2):316-20. PubMed ID: 1908549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphate and glucuronic acid conjugation of harmol in human fetal and adult liver tissue.
    Steiner E; von Bahr C; Rane A
    Dev Pharmacol Ther; 1982; 5(1-2):14-20. PubMed ID: 7151633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver.
    Murdoch RT; Ghabrial H; Mihaly GW; Morgan DJ; Smallwood RA
    Xenobiotica; 1991 Dec; 21(12):1571-82. PubMed ID: 1785204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of hypoxia and fasting on harmol elimination in the isolated perfused rat liver.
    Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
    Biochem Pharmacol; 1988 Apr; 37(7):1207-12. PubMed ID: 3355595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
    Xu X; Tang BK; Pang KS
    J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-cysteine as a selective precursor for inorganic sulfate in the rat in vivo. Effect of D-cysteine on the sulfation of harmol.
    Glazenburg EJ; Jekel-Halsema IM; Baranczyk-Kuzma A; Krijgsheld KR; Mulder GJ
    Biochem Pharmacol; 1984 Feb; 33(4):625-8. PubMed ID: 6704178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.